04Recent Activity
Participated in Kairos's $2.4M seed round for on-chain interest rate swap protocol.
MAR 2026
Kairos Pharma is a clinical-stage biopharmaceutical company that has developed novel therapies to overcome resistance to cancer drugs and reverse cancer-induced immune suppression
Kairos Pharma is a clinical-stage biopharmaceutical company that has developed novel therapies to overcome resistance to cancer drugs and reverse cancer-induced immune suppression.